RxDoctor Payments Data

Ashley Martin

Nurse Practitioner · Savannah, GANPI 1619523016

Payments from drug & device makers

$5,633in general payments, 2019–2025

Across 257 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Vifor Pharma, Inc.$695
  • Travere Therapeutics, Inc.$550
  • AstraZeneca$479
  • OPKO Pharmaceuticals, LLC$467
  • Otsuka America Pharmaceutical, Inc.$453
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$5,34895%
  • Education$2855%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,633 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol75$84,298
MounjaroTirzepatide34$38,055
OzempicSemaglutide29$36,642
JardianceEmpagliflozin14$18,808
Calcium Acetate32$2,913
Bumetanide68$2,613
Sevelamer Carbonate12$1,880
Midodrine Hcl19$1,639
Spironolactone78$1,255
Allopurinol79$886
Olmesartan Medoxomil85$813
SynthroidLevothyroxine Sodium12$717
Potassium Chloride20$714
Furosemide139$529
Metoprolol Succinate26$460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$479$84,29875 claims
Lilly USA, LLCMounjaro$14$38,05534 claims
Novo NordiskOzempic$136$36,64229 claims
Boehringer IngelheimJardiance$41$18,80814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →